Pilot trial demonstrates improved oxygen management during exercise in chronic respiratory disease, implying enhanced therapy effectiveness.
Extract Dyspnoea is the predominant symptom limiting exercise tolerance in people with chronic respiratory disease [4] and is often accompanied by exertional desaturation, with or without chronic hypoxaemia, during pulmonary rehabilitation (PR). Supplemental oxygen (O₂) is frequently prescribed to maintain oxygen saturation (SpO₂)≥90% [1, 2]. However, fixed O₂-flow rates cannot adapt to changing O₂-needs during activity, which may still lead to desaturation [3], increased dyspnoea, and early termination of exercise, particularly during endurance training.
No takes yet. Share an insight, caveat, or question.
Schneeberger et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: